Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000033389Phase 4Recruiting
Phase 4, randomised, open-label trial of bupivacaine and azasetron in postoperative ileus (POI) (4 arms), sponsored by The Affiliated Hospital of Yangzhou University. Primary endpoint: Postoperative first exhaust time. Started May 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000033389.